has been added to your cart.
Christine G. Stone
Jason D. Stone
Bankruptcy: Chapter 11
Bankruptcy Process: Chapter 11
Bankruptcy: Chapter 7
Bankruptcy: Chapter 13
How Do I Qualify for Bankruptcy?
Judgments in Bankruptcy
What Is Bankruptcy?
Business Litigation Representation
Business Succession Planning
Franchise Agreements: New Jersey
Interfering with Business Practices – Tortious Interference
Mergers, Acquisitions and Divestitures
Occupational Safety and Health Administration (OSHA)
Starting a New Business
Are Song Lyrics Protected by Copyright?
DMCA – Digital Millenium Copyright Act
How do I register a copyright?
How do I get a copyright?
Open Source Software Licensing
Terminating a Copyright Transfer
What is copyright infringement?
What Is A Poor Man’s Copyright?
What Is A Copyright?
Cease and Desist Letter
Intellectual Property Holding Companies
What Is Intellectual Property?
Other Practice Areas
What Is Aviation Law?
Reasons To Use A Real Estate Attorney
Online Will Questionnaire
Health Care Proxy
Power of Attorney
Avoiding Patent Rejection
Capitalizing On Your Patent
Patent Rights – Who Owns the Patent? Employee or Employer?
Public Use Bar for Patent Eligiblity
What Is A Patent?
Maintaining Your Trademark
Registering Your Trademark
Trademark Infringement and Defense
What Is A Trademark?
Online Legal Services
CAFC Nixes District Court Claim Construction in Win for Firearms Patent Owner
Tips for Litigating Multiple Simultaneous Patent Infringement Investigations at the ITC
SCOTUS, Vaccine Mandates and Patent Law: God Help Us
New Vision Gaming’s Motion for Reconsideration Highlights Issues with Arthrex USPTO Director Review Mandate
Unified Report: Reexaminations Double; Samsung, Apple and Google Dominate PTAB Filings
In Dissent to CAFC Ruling for Novartis on Written Description, Chief Judge Argues ‘Silence is not Disclosure’
Chief Justice Orders Review of Venue, Case Assignment for Patent Cases in Western District of Texas
SEPs in Europe and Beyond: Highlights From 2021
Top 2021 FRAND/RAND Licensing Developments in the United States: Part II
mRNA IP and Competitive Landscape: 2021 in Review – Part I, Update on Moderna, BioNTech, and CureVac